Manteio Capital’s KALA BIO KALA Stock Holding History

Manteio Capital’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8	Closed	-$24K	–	104
2021 Q4	$24K	Buy	+8	New	+$37.1K	0.03%	248

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

VAFP

Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return

Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manteio Capital's KALA Position: Q1 2022 in Review

Manteio Capital sold out of KALA BIO (KALA) in Q1 2022, closing a stake of 8 shares — an estimated $24K sold.

Manteio Capital first reported a position in KALA in Q4 2021 and held it in 1 quarter. The position peaked at $24K in Q4 2021. 82 funds tracked by Wall St. Rank hold KALA as of Q1 2022.

Manteio Capital reported no remaining KALA BIO position as of Q1 2022 after selling out during the quarter.
Manteio Capital sold 8 KALA BIO shares in Q1 2022, an estimated $24K.
Manteio Capital first reported a position in KALA BIO in Q4 2021 and held it in 1 quarter.
Manteio Capital's KALA BIO position peaked at $24K in Q4 2021.
82 funds tracked by Wall St. Rank held KALA BIO as of Q1 2022.

Based on Manteio Capital's 13F filing for Q1 2022.